Find a clinical trial
A clinical trial is a research study that people can join. Some test a new treatment. Some test a new way to use a treatment we already have. Joining one is always your choice.
How to think about a clinical trial covers what taking part involves, when to ask, and what the phases mean.
Talk to your care team before you contact a trial. They know your history and can tell you whether a trial is worth your time. Nothing on this page is medical advice, and we are not part of any trial.
Trials near you
Enter your ZIP code to see open trials with a site within 50 miles. We use your ZIP only to run that search. We do not store it.
This box works for US ZIP codes only. Outside the US, use the country filter below to see trials in your country. It will not tell you how far away they are.
Trials by countries
Showing 478 trials. Trials we know are closed are left out. This list is the brain tumor trials we track, not every trial on ClinicalTrials.gov. The search above looks at all of them.
-
Testing a radiation drug for meningioma that has come back
This study tests a drug that carries radiation to meningioma tumors that grew back after earlier treatment.
-
Adding Ruxolitinib to Radiation and Temozolomide for Newly Diagnosed Glioblastoma
This study is testing whether adding a drug called ruxolitinib to usual treatment helps people with newly diagnosed glioblastoma.
-
Adding vorasidenib to temozolomide after radiation for grade 3 astrocytoma
This trial is testing whether adding a drug called vorasidenib to usual chemotherapy helps people with newly diagnosed grade 3 astrocytoma.
-
Arsenic trioxide added to chemotherapy for children whose medulloblastoma came back
This study tests a drug called arsenic trioxide, added to chemotherapy, in children whose brain tumor came back.
-
A study of several treatments for new and returning glioblastoma
This study looks at more than one treatment for a brain tumor called glioblastoma.
-
Comparing two ways to give focused radiation to brain tumors that spread from other cancers
This study compares one dose of focused radiation with the same treatment split into more than one dose.
-
Collecting samples and health data from people getting radiation
This study collects samples to learn how radiation works and why it causes side effects.
-
A study of gene changes in twins when one twin has a brain or spine tumor
This study asks why one twin got a tumor and the other twin did not.
-
A cell therapy called EB103 for adults with B-cell lymphoma that came back
This study is testing a cell therapy for adults whose B-cell lymphoma came back or never went away.
-
Testing a mix of drugs and a tumor vaccine for glioma that is still there after treatment
This study tests if a drug and vaccine mix is safe for leftover glioma.
-
Testing tirabrutinib against a two-drug combination for primary CNS lymphoma that came back
This trial compares one drug, tirabrutinib, with a two-drug treatment in people whose primary central nervous system lymphoma has come back or did not respond.
-
Testing GI-102 with and without pembrolizumab before surgery for a returning grade 4 brain tumor
This trial tests a new immune drug, given before surgery, for a grade 4 brain tumor that has come back or is growing.
-
Focused Radiation Plus a Targeted Drug for HER2 Positive Breast Cancer in the Brain
This study tests a targeted drug given with focused radiation for breast cancer that has spread to the brain.
-
A Higher Dose of Proton Radiation for Pituitary Tumors That Make Hormones
This study asks if a stronger dose of radiation can help bring hormone levels back to normal.
-
Testing Endostar for brain swelling after radiation in lung cancer that spread to the brain
This trial tests a drug called Endostar for brain swelling after a focused radiation treatment.
-
A spinal fluid test to find and track brain lymphoma
This study tests whether a spinal fluid sample can spot brain lymphoma and follow it over time.
-
Radiation given before surgery for high grade glioma
This study tests a strong, focused dose of radiation given before brain tumor surgery.
-
Testing GD2 CAR T Cells in Children and Young Adults With Brain Tumors
This study tests changed immune cells in young people whose brain tumor came back.
-
Regorafenib for Recurrent Meningioma (MIRAGE Trial)
From the trial team: The focus of this study will be to investigate whether Regorafenib demonstrates antitumor activity against recurrent meningiomas.
-
Testing lab-changed immune cells in people whose glioblastoma has come back
This study tests immune cells that are changed in a lab so they can find and kill brain tumor cells.
Trial information comes from ClinicalTrials.gov, a service of the U.S. National Library of Medicine. We copy it as it is published there and do not change it. Always check the trial's own page for the latest.